Creative Medical Technology Holdings financials
$0.9652−4.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $3.0K | $0.00 | $0.00 | $3.0K | $3.0K | $0.00 | $8.0K | $0.00 | $3.0K | $6.0K |
| Gross profit | $0.00 | $0.00 | $2.0K | $0.00 | $0.00 | $1.8K | $1.8K | $0.00 | $4.8K | $0.00 | $1.8K | $3.6K |
| Gross margin | — | — | 66.9% | — | — | 60.0% | 60.0% | — | 60.0% | — | 60.0% | 60.0% |
| Operating income | -$1.6M | -$1.5M | -$1.9M | -$1.3M | -$1.3M | -$1.7M | -$1.9M | -$1.1M | -$1.6M | -$1.1M | -$1.8M | -$1.5M |
| Net income | -$1.5M | -$1.4M | -$1.9M | -$1.2M | -$1.2M | -$1.6M | -$1.9M | -$1.0M | -$1.6M | -$1.0M | -$1.7M | -$1.5M |
| Net margin | — | — | −62922.5% | — | — | −54603.2% | −61802.5% | — | −19471.6% | — | −55952.5% | −24232.5% |
| Diluted EPS | $-0.41 | $-0.38 | $-0.79 | $-0.48 | $-0.48 | $-0.83 | $-1.09 | $-0.75 | $-1.11 | $-0.73 | $-1.22 | $-1.02 |
| EBITDA | -$1.5M | -$1.4M | -$1.9M | -$1.2M | -$1.2M | -$1.6M | -$1.9M | -$1.1M | -$1.6M | -$1.1M | -$1.7M | -$1.5M |
| Operating cash flow | -$1.5M | -$1.3M | -$1.9M | -$1.2M | -$1.2M | -$1.6M | -$1.9M | -$985.6K | -$1.5M | -$896.9K | -$1.9M | -$1.3M |
| Free cash flow | -$1.5M | -$1.3M | -$1.9M | -$1.2M | -$1.2M | -$1.6M | -$1.9M | -$985.6K | -$1.5M | -$896.9K | -$1.9M | -$1.3M |
| Diluted shares | 3.7M | 3.7M | 2.4M | 2.6M | 2.6M | 2.0M | 1.7M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.7M | $5.7M | $7.2M | $5.4M | $6.5M | $7.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $9.4M | $6.4M | $7.8M | $5.9M | $7.1M | $8.3M |
| Total liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K |
| Shareholders' equity | $8.7M | $6.1M | $7.5M | $5.6M | $6.8M | $8.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology